Keyphrases
Treatment-resistant Depression
100%
Human Spermatozoa
100%
Human Endothelial Cells
66%
Remission
66%
Vascular Endothelial Growth Factor
66%
Placental Growth Factor (PlGF)
66%
Pericytes
66%
Electromagnetic Field
66%
Transcranial
63%
Lymphangiogenesis
60%
Lymph Node Metastasis
60%
Vitamin D
54%
Ca2+
50%
Lymphatic Endothelial Cells
50%
VEGFR-3
44%
CYP24A1
40%
Acrosome Reaction
40%
Human Sperm Functions
40%
Tumor Growth
40%
Semen Quality
37%
Annulus
37%
Progesterone
37%
Vascular Endothelial Growth factor-C (VEGF-C)
36%
1,25(OH)2D3
34%
Tumor-associated Macrophages
33%
UV Filters
33%
Cancer-associated Retinopathy
33%
VEGF Receptor 1
33%
Pancreatic β-cells
33%
Jurkat
33%
Rat Mesenteric Artery
33%
Metastasis
33%
Tumor Metastasis
33%
Neutrophils
33%
Platelet-derived Growth factor-BB (PDGF-BB)
33%
Tube Formation
33%
Human Lymphatic Endothelial Cells
33%
Interleukin-27 (IL-27)
33%
Glucagon-like
33%
Barrier Function
33%
Interferon-γ
33%
T Cell Activation
33%
Repaglinide
33%
Living Tissue
33%
Low-frequency Pulsed Electromagnetic Fields
33%
Induced Activation
33%
Endothelial Fenestrations
33%
Vascular Permeability
33%
Small GTP-binding Proteins
33%
IL-20
33%
Medicine and Dentistry
Lymphangiogenesis
100%
Metastatic Carcinoma
100%
Endothelial Cell
86%
Vasculotropin C
75%
Vitamin D
66%
Electromagnetic Field
66%
Platelet Derived Growth Factor
66%
Neoplasm
66%
Lymph Node Metastasis
59%
Lymph Duct
58%
Macrophage
47%
Fibroblast Growth Factor 2
42%
Intracellular Calcium
41%
Sperm Motility
40%
Blood Vessel Permeability
36%
T Lymphocyte Receptor
33%
Placebo-Controlled Study
33%
Interleukin-33
33%
Glucagon Like Peptide 1
33%
Retinopathy
33%
Placental Growth Factor
33%
Tumor Necrosis Factor
33%
Endothelial Fenestration
33%
Rac Protein
33%
Vasculotropin
33%
CYP24A1
33%
Major Histocompatibility Complex
33%
Cell Signaling
33%
Stromal Cell
33%
Gene Expression
33%
Knee Osteoarthritis
33%
Vasculotropin A
33%
Cell Proliferation
33%
Pericyte
33%
Mesenteric Artery
33%
CD3 Antigen
33%
Alpha Chemokine
33%
Stromal Cell Derived Factor 1alpha
33%
T Cell Activation
33%
Mammalian Target of Rapamycin
25%
In Vitro
24%
Angiogenesis
16%
Cancer Cell
16%
